Sarina Trangle started as a corporate news reporter in October 2024. She previously spent four years on the business desk at Newsday, covering the health industry, commercial real estate and cannabis.

Jennifer Garner and fellow Once Upon a Farm cofounder Cassandra Curtis are celebrating a major milestone for the children’s nutrition company, which went public on the New York Stock Exchange Feb. 6.

Clear Street's Billion-Dollar IPO Ambitions are A Taste of What's to Come as Wall Street Prepares for a Year of Groundbreaking Debuts… 2026 is gearing up to be the year of the IPO boom, and Clear ...

Once Upon a Farm PBC, the organic kids snacks maker co-founded by actress Jennifer Garner, and some of its investors raised $197.9 million in an initial public offering that priced at the midpoint of ...

SpyGlass Pharma Inc., a biopharmaceutical firm focused on solutions for chronic eye conditions, raised $150 million in a US initial public offering that priced at the midpoint of its marketed range.

Updates on Feb. 6, 7:05 AM ET, with company comment, context on equity markets. Liftoff Mobile (LFTO), an AI-powered marketing app backed by Blackstone (BX), is postponing its initial public offering ...

Belgian biotech Agomab Therapeutics and eye-focused drug delivery company SpyGlass Pharma both headed to the Nasdaq this morning as momentum continues to build for biopharma IPOs. Agomab is offering ...

A roughly $1 billion initial public offering by Malaysia’s Sunway Healthcare is drawing interest from high-profile investors like AIA, J.P. Morgan Asset Management and International Finance Corp. The ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

In 2025, the initial public offering (IPO) market continued to rebound from the 2022 and 2023 slump. For the second year in a row, markets saw more IPOs, more special purpose acquisition companies ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Eikon Therapeutics increased the ...